Hi everyone,
I would like to raise a naming issue that we identified while reviewing a recent submission.
Current LOINC codes related to delafloxacin use ABT492 as the Component name. ABT492 was the development name for delafloxacin and is rarely used in current clinical or laboratory practice. For example, 41659-4 uses ABT492 as the Component.
There are also deprecated terms that use Delafloxacin directly as the Component, such as 90447-4, but these are mapped to active codes using ABT492.
Because users will usually search for the current drug name, this can make the relevant codes difficult to identify. Adding Delafloxacin as a synonym improves searchability, but the preferred Component name remains ABT492.
We would therefore like to ask whether the preferred naming of these terms could be reconsidered, or whether another approach would be more appropriate to better reflect current usage.
Thank you very much.
Best regards,
Ivan